| CAS ID: | 26921-17-5 |
| Molecular Formula: | C17H28N4O7S |
| Molecular Weight: | 316.4 g/mol |
| Monoisotopic Mass: | 316.1569 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | TIMOLOL MALEATE | Timoptic XE | TIMOPTIC-XE | BLOCADREN | TIMOPTIC IN OCUDOSE | TIMOPTIC | ISTALOL |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C13H24N4O3S.C4H4O4/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17;5-3(6)1-2-4(7)8/h10,14,18H,4-9H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t10-;/m0./s1 | See All |
| InChI Key: | WLRMANUAADYWEA-NWASOUNVSA-N | |
| Smiles: | CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2.OC(=O)\C=C/C(=O)O | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00006398 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | October 6, 2000 | Last Verified | June 1, 2017 |
| Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | ||
| PubChem: | 5281056 |
| ChEMBL: | CHEMBL1200870 |